[Previous] An H1N1 Seroprevalence Study...

 [Next] A TIME'S MEMORY: Egypt's H5N1 cases top 100 (CIDRAP, e...

Some related posts from Technorati and Google.

[Science Blog] Tips from the Journals of the American Society for Microbiology ...: History shows vaccines to be the most effective strategy against pandemic infectious diseases such as smallpox, polio, measles and yellow fever, however, the control of HIV not only relies on the production of neutralizing antibodies, but also the development of high frequency, broadly targeted T-cell responses specific to the virus. To date live-attenuated simian immunodeficiency virus (SIV)/HIV vaccines have prompted the most significant immune response against AIDS in a nonhuman primate model, but risk of redeveloping pathogenic forms makes them ineligible for human use.

[Executive Healthcare Management] Pigs might fly | GDS Publishing: Working on the paper, a team of scientists from the US, Indonesia and Japan, led by virologist Yoshihiro Kawaoka at the University of Wisconsin, Madison, combined a strain of the deadly H5N1 avian virus with strains of H3N2 human seasonal flu, creating 254 new, mutated viruses. By injecting them in lab mice, researchers found that some of the hybrid viruses were both deadly (like bird flu) and transmissible (like seasonal human flu) - the kind of genetically mutated superflu viruses that experts have been warning about for decades.

[Wealth Daily] H1N1 Swine Flu Panic: In a turn of events, one clinic in New York has even hired a fellow to stand at an intersection and wave a giant sign announcing ''FREE TODAY: H1N1 Flu Shots for All'' to dig up some prospects. Last fall, the line at the same clinic was stretched a quarter mile down the street.

[Flu Wiki Forum - Recent Comments] Publication of Vical's H5N1 Results Paves the Way for H1N1 ...: 24, 2010 (GLOBE NEWSWIRE) -- Vical Incorporated announced today the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of the company's Vaxfectin(R)-adjuvanted DNA vaccines for H5N1 (avian-origin) influenza, demonstrating the potential of DNA vaccines for rapid deployment in future pandemics.

[Flu News Blog] Publication of Vical's H5N1 Results Paves the Way for H1N1 ...: announced today the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of the company’s Vaxfectin(R)-adjuvanted DNA vaccines for H5N1 (avian-origin) influenza, demonstrating the potential of DNA vaccines for

[H1N1 TREATMENT US] Publication of Vical's H5N1 Results Paves the Way for H1N1 ...: Vical Incorporated announced today the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of the company’s Vaxfectin-adjuvanted DNA vaccines for H5N1 influenza, demonstrating the potential of DNA vaccines for rapid deployment in future pandemics.

[All news.] Publication of Vical's H5N1 Results Paves the Way for H1N1 ...: The trials were designed to assess safety and immunogenicity following vaccination, and to evaluate monovalent and trivalent Vaxfectin®-formulated H5N1 pandemic influenza DNA vaccines at various doses. The vaccines were well-tolerated in the trial, and induced antibody responses and T-cell responses against a matching strain of influenza virus, and cross-clade antibody responses against different strains.

[Vaccine Resistance Movement] VRM: Vaccine Ingredients « Vaccine Resistance Movement: In addition to the viral and bacterial RNA or DNA that is part of the vaccines, here are the fillers: .VaccineResist: Rockefeller funded BIO WEAPON COCKTAIL: H1N1 (Swine) + H1N2 (Swine) + H5N1 (Bird) + H3N2 (Human) + BACTERIA = PANDEMIC www.ncbi.nlm.nih.gov.

[Coach McGaha's Science Blog] Physics 2-23-10 (Tue) | Coach McGaha's Science Blog: Researchers from Hungary and the UK have developed a single-dose H5N1 influenza vaccine that induces a protective level of immunity against infection in healthy adult and elderly volunteers. The vaccine is the first single-dose regimen to be tested in elderly subjects and it fulfills all European Union and U.S. licensing criteria offering a promising influen […]

[WooEB Blog] PWRM, TTIL, CRWEWallstreet.com Stock Report! 02/24/2010, CVAT ...: Vical Incorporated (Nasdaq:VICL) announced today the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of the company's Vaxfectin®-adjuvanted DNA vaccines for H5N1 (avian-origin) influenza, demonstrating the potential of DNA vaccines for rapid deployment in future pandemics.

[Technology Review Feed - arXiv blog] Technology Review: Caterpillar Flu Vaccine Delayed: Medicago's VLP-based vaccine has shown in preclinical studies it can provide cross- protection against different strains of avian flu, such as the Vietnam and Turkey strains. As Medicago's technology requires the genetic sequence of a viral strain and not the live influenza virus, vaccines can be manufactured within 4 weeks of obtaining the genetic sequence ofthe pandemic strain.

[openUReyes] H1N1 Vaccine Unsafe For Pregnant Women And Children? | openUReyes: Such testing could provide vaccine recipients with assurance that the vaccine is not contaminated with H5N1, SV40, any other adventitious microorganisms, oncogenic DNA fragments or any other inadvertent contaminants that could pose a health risk. In other words, The Ministry of Health is relying solely on information supplied by Baxter - which has a massive financial interest in its products - attesting to the safety and efficacy of "Celvapan".

[Bird Flu Monitor] Bird Flu Monitor: Is a Bird Flu Vaccine Really Effective?: ..: Since 2003 the H5N1 strain of avian influenza has spread rapidly out of Asia and into parts of Europe killing along the way more than 150 people and millions of birds, who have either .COM Blog: Canada announced Thursday it has donated five million swine flu vaccine doses and six million Canadian dollars (5.6 million US) to the World Health Organization for its pandemic relief efforts.

[From Hell To Veins] H1N1, H2N2, H3N2, and H5N1 Combo DNA Influenza Vaccine Ready: Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets. In addition, ferrets immunized with Inovio’s SynConTM universal flu vaccine combinations were 100% protected against death and sickness in a challenge with the A/H1N1 (2009) swine-origin influenza.

Reflected tags on Technorati: Blog, H5n1, Bird Flu Monitor